Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_assertion type Assertion NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_head.
- NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_assertion description "[This study revealed the following characteristics of these disorders: 1) subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome (including hypomagnesemia, hypocalciuria, and fractional chloride excretion insensitivity to thiazide administration); and 2) subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_provenance.
- NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_assertion evidence source_evidence_literature NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_provenance.
- NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_assertion SIO_000772 20810575 NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_provenance.
- NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_assertion wasDerivedFrom befree-20150227 NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_provenance.
- NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_assertion wasGeneratedBy ECO_0000203 NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_provenance.